Radiation units: gray and sievert

Clinical relevance (anaesthesia)

  • Most perioperative radiation exposure is from diagnostic imaging (fluoroscopy, CT, nuclear medicine) and is reported as effective dose (Sv); tissue injury risk relates more to absorbed dose (Gy) at the skin/organ.
    • Examples: C-arm fluoroscopy in orthopaedics/vascular, interventional radiology, cardiac cath lab, CT trauma imaging.
  • Deterministic effects (threshold; severity increases with dose) are linked to high local absorbed dose (Gy).
    • Skin erythema, epilation, cataract, tissue necrosis; foetal malformations (timing-dependent).
  • Stochastic effects (no threshold; probability increases with dose) are linked to effective dose (Sv).
    • Cancer induction and heritable effects (the latter very low/uncertain in humans at diagnostic doses).
  • Staff monitoring uses personal dosimeters; limits are expressed in Sv (usually mSv).
    • Typical workplace aim: keep exposures ALARP; pregnant staff have tighter constraints.

Core definitions and relationships

  • Absorbed dose (Gray, Gy) = energy absorbed per unit mass.
    • 1 Gy = 1 joule per kilogram (1 J·kg⁻¹).
    • Purely physical quantity; does not account for radiation type or tissue sensitivity.
  • Equivalent dose (Sievert, Sv) = absorbed dose weighted for radiation type (biological effectiveness).
    • H_T = D_T,R × w_R
    • Units: Sv (because w_R is dimensionless).
  • Effective dose (Sievert, Sv) = sum of equivalent doses to tissues weighted for tissue radiosensitivity (whole-body detriment).
    • E = Σ w_T × H_T
    • Used to compare risk across different investigations and non-uniform exposures; not intended for individual patient risk prediction.
  • Key point: Gy measures energy deposition; Sv estimates biological harm/risk (via weighting factors).

Weighting factors (what you need to know)

  • Radiation weighting factor (w_R) reflects relative biological effectiveness (RBE) for stochastic effects.
    • Photons (X-rays, γ) and electrons/β: w_R = 1.
    • Protons: commonly w_R ≈ 2 (varies with energy).
    • Alpha particles: w_R = 20.
    • Neutrons: energy-dependent (often quoted range ~5–20; some tables peak higher). In exams, state energy-dependent and higher than photons.
  • Tissue weighting factor (w_T) reflects contribution of that tissue to overall stochastic detriment.
    • High w_T tissues classically include: bone marrow, colon, lung, stomach, breast, gonads (exact values depend on ICRP version).
    • Sum of w_T across all tissues = 1.

Conversions and typical magnitudes

  • If radiation is X-ray/γ (w_R = 1): 1 Gy to a tissue ≈ 1 Sv equivalent dose to that tissue.
    • But effective dose depends on which tissues were irradiated and their w_T; it is usually much lower than local absorbed dose for a small field.
  • Historical units: rad and rem.
    • 1 rad = 0.01 Gy; 1 Gy = 100 rad.
    • 1 rem = 0.01 Sv; 1 Sv = 100 rem.
  • Background radiation (UK): order of a few mSv per year (varies with geography and medical exposure).

Dose quantities you may see in imaging (and how they relate)

  • CTDIvol (mGy): scanner output index for CT (dose in a standard phantom; not patient-specific absorbed dose).
  • DLP (mGy·cm): CT dose-length product; can be converted to effective dose using region-specific conversion factors (k).
    • E (mSv) ≈ k × DLP (mGy·cm), where k depends on body region and patient size/age.
  • DAP/KAP (Gy·cm²): dose-area product in fluoroscopy; correlates with stochastic risk and is used for audit/trigger levels.
  • Entrance skin dose / peak skin dose (Gy): relevant to deterministic skin injury in prolonged fluoroscopy.

Regulatory/occupational context (high-yield)

  • Occupational limits are expressed as effective dose (mSv) and equivalent dose (mSv) to specific tissues (e.g., lens of eye, skin, extremities).
    • Know the concept: whole-body effective dose limit vs organ-specific equivalent dose limits; exact numbers can change with regulations—quote principles and local policy if unsure.
  • Pregnancy: foetal dose should be kept very low; monitoring and work modification may be required depending on exposure environment.
Define the Gray and the Sievert. How do they differ?

Start with physical vs biological quantities, then give the equations.

  • Gray (Gy): absorbed dose = energy absorbed per unit mass; 1 Gy = 1 J·kg⁻¹.
  • Sievert (Sv): dose quantities adjusted for biological effect.
    • Equivalent dose: H_T = D × w_R (radiation weighting).
    • Effective dose: E = Σ w_T × H_T (tissue weighting).
  • Gy is purely physical; Sv estimates biological detriment/risk and depends on radiation type and tissues exposed.
A tissue receives 0.2 Gy from alpha particles. What is the equivalent dose to that tissue?

Use H = D × wR.

  • For alpha particles, w_R = 20.
  • H = 0.2 Gy × 20 = 4 Sv (equivalent dose to that tissue).
Why can 1 Gy sometimes be numerically similar to 1 Sv, and why is that potentially misleading?

This is a common FRCA viva trap: distinguish equivalent vs effective dose and field size.

  • For X-rays/γ, w_R = 1, so equivalent dose (Sv) = absorbed dose (Gy) for that tissue.
  • However effective dose also includes tissue weighting (w_T) and depends on which organs are irradiated and how uniformly.
  • A small-field high skin dose (Gy) may correspond to a much smaller effective dose (Sv), yet still cause deterministic skin injury.
Differentiate deterministic and stochastic radiation effects, and link each to Gy or Sv.

Define, then relate to dose metrics used clinically.

  • Deterministic: threshold exists; severity increases with dose; related to local absorbed dose (Gy).
    • Examples: skin erythema/burn, cataract, tissue necrosis.
  • Stochastic: no threshold; probability increases with dose; related to effective dose (Sv).
    • Example: cancer induction.
What are radiation weighting factors (wR)? Give typical values for common radiations used in medicine.

Focus on the high-yield ones and mention neutrons are energy-dependent.

  • w_R accounts for differing biological effectiveness per unit absorbed dose.
  • X-rays/γ and β: w_R = 1.
  • Alpha: w_R = 20.
  • Neutrons: energy-dependent, generally >1 (often quoted ~5–20).
What is tissue weighting (wT) and why do we need it?

Explain effective dose as a risk-comparison tool.

  • w_T reflects relative radiosensitivity and contribution of each organ/tissue to overall stochastic detriment.
  • Effective dose: E = Σ w_T × H_T; allows comparison of non-uniform exposures (e.g., CT chest vs CT head).
  • Σw_T = 1 across all tissues.
A CT report provides CTDIvol and DLP. Which is closer to absorbed dose, and which is used to estimate effective dose?

Clarify what each metric represents and how it is used.

  • CTDIvol (mGy): scanner output index (phantom-based); closer in concept to dose but not patient-specific absorbed dose.
  • DLP (mGy·cm): incorporates scan length; commonly used with region-specific conversion factor to estimate effective dose (mSv).
    • E ≈ k × DLP (k depends on region/age/size).
In fluoroscopy, what is DAP/KAP and what does it correlate with?

Common FRCA physics viva: distinguish DAP from skin dose.

  • DAP/KAP (Gy·cm²) = dose × irradiated area; relatively independent of distance from source (in idealised geometry) because dose falls with distance but beam area increases.
  • Correlates with stochastic risk (overall energy imparted) and is useful for audit/trigger levels.
  • Does not directly give peak skin dose; prolonged procedures can still cause high skin absorbed dose (Gy).
Convert 250 mrad to Gy, and 75 mrem to Sv.

Use 1 rad = 0.01 Gy; 1 rem = 0.01 Sv.

  • 250 mrad = 0.250 rad = 0.250 × 0.01 Gy = 0.0025 Gy (2.5 mGy).
  • 75 mrem = 0.075 rem = 0.075 × 0.01 Sv = 0.00075 Sv (0.75 mSv).
Why is effective dose (Sv) not ideal for estimating an individual patient’s risk from a specific scan?

Key limitations: population-averaged, model-based, not personalised.

  • Effective dose uses reference phantoms and population-averaged tissue weighting factors; it is designed for radiation protection and comparison, not individual prognosis.
  • Patient-specific factors (age, sex, body habitus, organ size, scan protocol) alter true organ doses and risk.
  • Uncertainty in low-dose risk models (linear no-threshold assumptions) adds further imprecision.

0 comments